Regional Health Pptys Inc Financials

RHEPB

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

This page shows Regional Health Pptys Inc (RHEPB) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Neutral

4/9

Regional Health Pptys Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

-0.60x

For every $1 of reported earnings, Regional Health Pptys Inc generates $-0.60 in operating cash flow ($1.9M OCF vs -$3.2M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

0.1x

Regional Health Pptys Inc earns $0.1 in operating income for every $1 of interest expense ($161K vs $2.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Revenue

$18.3M

YoY+6.8%

5Y CAGR-1.9%

10Y CAGR+18.6%

Regional Health Pptys Inc generated $18.3M in revenue in fiscal year 2024. This represents an increase of 6.8% from the prior year.

EBITDA

$2.2M

YoY+55.0%

5Y CAGR-24.2%

Regional Health Pptys Inc's EBITDA was $2.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 55.0% from the prior year.

Free Cash Flow

$1.4M

YoY-48.7%

5Y CAGR-9.6%

Regional Health Pptys Inc generated $1.4M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 48.7% from the prior year.

Net Income

-$3.2M

YoY+17.2%

Regional Health Pptys Inc reported -$3.2M in net income in fiscal year 2024. This represents an increase of 17.2% from the prior year.

EPS (Diluted)

$-1.73

YoY-108.2%

Regional Health Pptys Inc earned $-1.73 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 108.2% from the prior year.

Cash & Debt

$582K

YoY-41.8%

5Y CAGR-33.3%

10Y CAGR-25.3%

Regional Health Pptys Inc held $582K in cash against $49.7M in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

YoY+2.2%

5Y CAGR+2.2%

Regional Health Pptys Inc had 2M shares outstanding in fiscal year 2024. This represents an increase of 2.2% from the prior year.

Gross Margin

N/A

Operating Margin

0.9%

YoY+5.7pp

5Y CAGR-26.3pp

10Y CAGR+728.6pp

Regional Health Pptys Inc's operating margin was 0.9% in fiscal year 2024, reflecting core business profitability. This is up 5.7 percentage points from the prior year.

Net Margin

-17.5%

YoY+5.1pp

5Y CAGR-44.9pp

10Y CAGR+391.4pp

Regional Health Pptys Inc's net profit margin was -17.5% in fiscal year 2024, showing the share of revenue converted to profit. This is up 5.1 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$530K

YoY-44.7%

5Y CAGR+55.7%

10Y CAGR-18.6%

Regional Health Pptys Inc invested $530K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 44.7% from the prior year.

RHEPB Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$18.3M+6.8%	$17.2M-52.2%	$35.9M+34.6%	$26.7M+51.8%	$17.6M-12.7%	$20.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$5.4M-0.1%	$5.4M+16.3%	$4.7M+18.3%	$3.9M+16.5%	$3.4M+5.7%	$3.2M
Operating Income	$161K+119.6%	-$821K+88.0%	-$6.8M-369.3%	$2.5M+10.4%	$2.3M-58.0%	$5.5M
Interest Expense	$2.7M-1.5%	$2.8M+8.8%	$2.5M-5.2%	$2.7M-3.9%	$2.8M-47.3%	$5.3M
Income Tax	N/A	N/A	N/A	N/A	N/A	$0
Net Income	-$3.2M+17.2%	-$3.9M+43.4%	-$6.9M-481.0%	-$1.2M-71.8%	-$688K-112.5%	$5.5M
EPS (Diluted)	$-1.73-108.2%	$21.05+335.7%	$-8.93-52.1%	$-5.87	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Revenue	$15.1M+50.5%	$10.1M+39.9%	$7.2M+27.1%	$5.7M+33.9%	$4.2M-2.3%	$4.3M+4.8%	$4.1M-8.7%	$4.5M
Cost of Revenue	$2.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$12.7M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$3.7M+52.9%	$2.4M+8.9%	$2.2M+68.6%	$1.3M+8.1%	$1.2M-0.4%	$1.2M-24.7%	$1.6M+44.4%	$1.1M
Operating Income	-$594K-16.9%	-$508K-59.7%	-$318K-158.8%	$541K+280.3%	-$300K-240.2%	$214K+172.8%	-$294K-284.9%	$159K
Interest Expense	$751K+22.1%	$615K-5.8%	$653K-5.4%	$690K+1.9%	$677K+1.2%	$669K-0.7%	$674K-1.5%	$684K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$3.4M+333.4%	-$1.4M-14.8%	-$1.3M-122.2%	-$568K+42.2%	-$982K-39.1%	-$706K+26.6%	-$962K-304.2%	-$238K
EPS (Diluted)	$1.17+272.1%	$-0.68+27.7%	$-0.94	N/A	$-0.52-36.8%	$-0.38+26.9%	$-0.52	N/A

RHEPB Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$60.5M-2.8%	$62.2M-9.3%	$68.6M-35.1%	$105.7M-2.2%	$108.0M-5.0%	$113.8M
Current Assets	N/A	N/A	N/A	N/A	N/A	$7.4M
Cash & Equivalents	$582K-41.8%	$1.0M+25.0%	$800K-88.2%	$6.8M+61.9%	$4.2M-4.5%	$4.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$3.4M+139.6%	$1.4M-77.7%	$6.3M+193.2%	$2.1M+2.1%	$2.1M+110.0%	$1.0M
Goodwill	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M
Total Liabilities	$63.4M+2.2%	$62.0M-4.4%	$64.9M-31.9%	$95.3M-1.7%	$96.9M-5.0%	$102.0M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	$14.1M
Long-Term Debt	$49.7M-2.0%	$50.7M-2.8%	$52.2M-1.3%	$52.9M-2.9%	$54.4M-1.7%	$55.4M
Total Equity	-$2.9M-1677.8%	$185K-95.0%	$3.7M-64.3%	$10.4M-6.4%	$11.1M-5.4%	$11.7M
Retained Earnings	-$85.1M-3.9%	-$81.9M+32.5%	-$121.4M-6.0%	-$114.5M-1.0%	-$113.4M-0.6%	-$112.7M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Total Assets	$72.2M+20.0%	$60.1M+1.4%	$59.3M-2.0%	$60.5M+0.7%	$60.1M-2.1%	$61.3M+0.2%	$61.2M-1.5%	$62.2M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.0M+150.0%	$400K-20.0%	$500K-14.1%	$582K+16.4%	$500K-28.6%	$700K-12.5%	$800K-20.0%	$1.0M
Inventory	$1.4M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$7.7M+76.7%	$4.4M+20.0%	$3.6M+8.3%	$3.4M+65.3%	$2.0M+11.9%	$1.8M+24.1%	$1.5M+4.3%	$1.4M
Goodwill	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M0.0%	$1.6M
Total Liabilities	$69.0M+5.2%	$65.6M+3.4%	$63.4M+0.1%	$63.4M+1.5%	$62.4M-0.5%	$62.7M+1.3%	$62.0M-0.1%	$62.0M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$48.6M-0.7%	$48.9M-0.5%	$49.2M-1.1%	$49.7M+0.1%	$49.7M-1.2%	$50.2M+0.5%	$50.0M-1.4%	$50.7M
Total Equity	-$1.5M+71.8%	-$5.5M-31.1%	-$4.2M-42.5%	-$2.9M-22.6%	-$2.4M-68.0%	-$1.4M-93.1%	-$734K-496.8%	$185K
Retained Earnings	-$84.8M+4.1%	-$88.4M-1.7%	-$87.0M-2.2%	-$85.1M-0.7%	-$84.6M-1.2%	-$83.6M-0.9%	-$82.9M-1.2%	-$81.9M

RHEPB Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$1.9M-47.7%	$3.7M+203.2%	-$3.6M-173.5%	$4.9M+277.9%	$1.3M-46.0%	$2.4M
Capital Expenditures	$530K-44.7%	$958K+240.9%	$281K+128.5%	$123K-72.7%	$450K+675.9%	$58K
Free Cash Flow	$1.4M-48.7%	$2.8M+171.0%	-$3.9M-181.3%	$4.8M+464.6%	$845K-63.9%	$2.3M
Investing Cash Flow	-$530K+44.7%	-$958K-240.9%	-$281K-128.5%	-$123K+72.7%	-$450K-111.8%	$3.8M
Financing Cash Flow	-$2.1M+14.3%	-$2.5M-20.2%	-$2.1M+14.6%	-$2.4M-73.6%	-$1.4M+70.2%	-$4.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	$46K+557.1%	$7K	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Operating Cash Flow	-$1.8M-416.2%	$569K+141.1%	$236K-75.2%	$953K+950.9%	-$112K-122.2%	$505K-15.4%	$597K+136.9%	$252K
Capital Expenditures	$283K-4.1%	$295K+353.8%	$65K-35.0%	$100K+185.7%	$35K-89.7%	$340K+518.2%	$55K+31.0%	$42K
Free Cash Flow	-$2.1M-859.9%	$274K+60.2%	$171K-80.0%	$853K+680.3%	-$147K-189.1%	$165K-69.6%	$542K+158.1%	$210K
Investing Cash Flow	$5.7M+2029.5%	-$295K-353.8%	-$65K+35.0%	-$100K-185.7%	-$35K+89.7%	-$340K-518.2%	-$55K-31.0%	-$42K
Financing Cash Flow	-$3.1M-2470.2%	-$121K+79.4%	-$587K+33.5%	-$883K-1277.3%	$75K+113.3%	-$566K+24.6%	-$751K-13.6%	-$661K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

RHEPB Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	0.9%+5.7pp	-4.8%+14.2pp	-19.0%-28.5pp	9.5%-3.6pp	13.1%-14.1pp	27.1%
Net Margin	-17.5%+5.1pp	-22.7%-3.5pp	-19.1%-14.7pp	-4.4%-0.5pp	-3.9%-31.2pp	27.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	46.8%
Return on Assets	-5.3%+0.9pp	-6.3%+3.8pp	-10.0%-8.9pp	-1.1%-0.5pp	-0.6%-5.5pp	4.8%
Current Ratio	N/A	N/A	N/A	N/A	N/A	0.52
Debt-to-Equity	-17.03-291.3	274.24+260.2	14.04+9.0	5.09+0.2	4.90+0.2	4.71
FCF Margin	7.7%-8.3pp	16.1%+26.8pp	-10.8%-28.7pp	17.9%+13.1pp	4.8%-6.8pp	11.6%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q3'24	Q2'24	Q1'24	Q4'23
Gross Margin	83.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-3.9%+1.1pp	-5.1%-0.6pp	-4.4%-14.0pp	9.6%+16.7pp	-7.1%-12.0pp	5.0%+12.1pp	-7.1%-10.6pp	3.5%
Net Margin	22.3%+36.8pp	-14.4%+3.1pp	-17.5%-7.5pp	-10.0%+13.2pp	-23.2%-6.9pp	-16.3%+7.0pp	-23.3%-18.1pp	-5.3%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	4.7%+7.1pp	-2.4%-0.3pp	-2.1%-1.2pp	-0.9%+0.7pp	-1.6%-0.5pp	-1.1%+0.4pp	-1.6%-1.2pp	-0.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	-31.59-22.6	-8.97+2.9	-11.82+5.2	-17.03+3.8	-20.86+14.6	-35.46+32.7	-68.13-342.4	274.24
FCF Margin	-13.8%-16.5pp	2.7%+0.3pp	2.4%-12.7pp	15.1%+18.6pp	-3.5%-7.3pp	3.8%-9.3pp	13.1%+8.5pp	4.6%

Note: Shareholder equity is negative (-$2.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Selectis Health Inc GBCS

$6.1M

Ethema Hlth GRST

$3.1M

Cardiff Lexingto CDIX

$29.5M

Numinus Wellness Inc. NUMIF

$11.7M

Biocorrx Inc BICX

$8.5M

Frequently Asked Questions

What is Regional Health Pptys Inc's annual revenue?

Regional Health Pptys Inc (RHEPB) reported $18.3M in total revenue for fiscal year 2024. This represents a 6.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Regional Health Pptys Inc's revenue growing?

Regional Health Pptys Inc (RHEPB) revenue grew by 6.8% year-over-year, from $17.2M to $18.3M in fiscal year 2024.

Is Regional Health Pptys Inc profitable?

No, Regional Health Pptys Inc (RHEPB) reported a net income of -$3.2M in fiscal year 2024, with a net profit margin of -17.5%.

What is Regional Health Pptys Inc's earnings per share (EPS)?

Regional Health Pptys Inc (RHEPB) reported diluted earnings per share of $-1.73 for fiscal year 2024. This represents a -108.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Regional Health Pptys Inc's EBITDA?

Regional Health Pptys Inc (RHEPB) had EBITDA of $2.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Regional Health Pptys Inc have?

As of fiscal year 2024, Regional Health Pptys Inc (RHEPB) had $582K in cash and equivalents against $49.7M in long-term debt.

What is Regional Health Pptys Inc's operating margin?

Regional Health Pptys Inc (RHEPB) had an operating margin of 0.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Regional Health Pptys Inc's net profit margin?

Regional Health Pptys Inc (RHEPB) had a net profit margin of -17.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Regional Health Pptys Inc's free cash flow?

Regional Health Pptys Inc (RHEPB) generated $1.4M in free cash flow during fiscal year 2024. This represents a -48.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Regional Health Pptys Inc's operating cash flow?

Regional Health Pptys Inc (RHEPB) generated $1.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Regional Health Pptys Inc's total assets?

Regional Health Pptys Inc (RHEPB) had $60.5M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Regional Health Pptys Inc's capital expenditures?

Regional Health Pptys Inc (RHEPB) invested $530K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How many shares does Regional Health Pptys Inc have outstanding?

Regional Health Pptys Inc (RHEPB) had 2M shares outstanding as of fiscal year 2024.

What is Regional Health Pptys Inc's debt-to-equity ratio?

Regional Health Pptys Inc (RHEPB) had a debt-to-equity ratio of -17.03 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Regional Health Pptys Inc's return on assets (ROA)?

Regional Health Pptys Inc (RHEPB) had a return on assets of -5.3% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Why is Regional Health Pptys Inc's debt-to-equity ratio negative or unusual?

Regional Health Pptys Inc (RHEPB) has negative shareholder equity of -$2.9M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Regional Health Pptys Inc's Piotroski F-Score?

Regional Health Pptys Inc (RHEPB) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Regional Health Pptys Inc's earnings high quality?

Regional Health Pptys Inc (RHEPB) has an earnings quality ratio of -0.60x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Regional Health Pptys Inc cover its interest payments?

Regional Health Pptys Inc (RHEPB) has an interest coverage ratio of 0.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.